Tuesday, February 08, 2011 11:21:00 PM
What company would want to own branded Copaxone if Teva and MNTA were joining forces to bring generic Copaxone to market? The answer is: nobody.
Teva will never be allowed to buy MNTA for the reasons you stated so this topic is moot. Regardless the assumption that nobody would want own branded Copaxone if MNTA/TEVA brought generic Copaxone to market ascribes no value to branded Copaxone under this scenario.
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
